Abstract: Small bowel bacterial overgrowth syndrome (SBBOS) is a disorder of excessive bacterial growth in the small intestine.
Introduction
The upper intestinal tract was once thought to be a sterile environment; however, low concentrations of various bacteria are now widely accepted to live within or attached to its luminal surface. These bacteria are thought to be present from the time of birth and through adulthood, living in symbiosis with the human host. This relationship is thought to be vital for normal digestive processes, immunity, and intestinal development. Bacterial species usually present include lactobacilli, enterococci, oral streptococci, and other gram-positive aerobic or facultative anaerobes (Sieczkowska et al., 2015) .
Various etiological processes can disrupt mechanisms that keep the number of these bacteria low. These include structural abnormalities (congenital or surgical) and disorders that cause decreased gastric acidity, reduced peristaltic activity, and mucosal damage or atrophy (Enko et al., 2015) . Small intestinal bacterial overgrowth has also been reported in progressive systemic sclerosis, jejuna diverticulosis, 33% of patients with portal hypertension, 36% of those with chronic renal failure, 59% of uncomplicated acute colonic diverticulosis, 54% of overt hypothyroidism,44% of acromegaly, and 96% of Cohn's disease with small-bowel strictures (Braun et al., 2015, Mooney et al., 2015 , Lauritano et al., 2007 .Bacterial overgrowth can cause a variety of symptoms, many of which are also found in other conditions, making the diagnosis challenging at times (, Paul et al., 2010 &Sieczkowska et al., 2015 . Many of the symptoms are due to mal absorption of nutrients due to the effects of bacteria which either metabolize nutrients or cause inflammation of the small bowel impairing absorption. The symptoms of bacterial over growth include nausea, flatus, constipation, bloating, abdominal distension, abdominal pain or discomfort, diarrhea, fatigue, and weakness. Children with bacterial overgrowth may developmal nutrition and have difficulty attaining proper growth (Sieczkowska et al., 2015 & Jan et al., 2010 . Several methods have been used to detect SBBOS, but each has its disadvantages. The gold standard for diagnosis is a small intestinal aspirate culture showing growth of ≥ 10 5 colony-forming units[CFUs]/mL of duodenal or jejunal fluid (Elphick 2tal 2006) .Noninvasive breath tests may be used to make a diagnosis of SBBOS, but these are labor-intensive and have shown wide-ranging sensitivity and specificity (Simre and Stotzer, 2996 & Enko et al., 2015) . Another Concern is the (minor) radiation exposure in breath testing using 14C-xylose or 14C-glycocholic acid (Guannarsson et al., 2007 
Materials and Methods

Study Population
This study was carried out in the gastroenterology unit of Internal Medicine, Microbiology and Histopathology departments, Faculty of Medicine, Zagazig University in Egypt. All the preliminary participants in the study referred to diagnostic upper gastrointestinal endoscopic examination for evaluation of unexplained gastrointestinal symptoms not responding to routine symptomatic medications such as nausea, bloating, vomiting, diarrhea, malnutrition, weight loss and mal-absorption for more than one month from June 2013 till May 2014. Both duodenal or jejunal aspirate cultures and corresponding duodenal biopsies was taken. Cultures were considered positive when there was growth of % at least10 5 CFUs/mL of gram-negative bacteria, aerobic or anaerobic, and negative when there was less than 10 5 CFUs/mL. Patients were excluded from the study if there was a history of upper gastrointestinal Cohn's disease or recent infection with enteric pathogens or if there was a clinical diagnosis of celiac disease or celiac serologic markers were found to be unequivocally positive.
The final study population comprised 49 consecutive patients meeting the above criteria: 28 patients (57.1%) with positivecultures and 21 control patients (41.9%) with negative cultures. Mandatory routine approval of the official ethical committeewas obtained from the Review Board plus informed consent from all the participants was taken.
Clinical Data
Thorough initial history taking and clinical evaluation of the all of the participants of the study focusing on age, sex, presenting symptoms, serologic tests for gluten sensitivity (antigliadin IgA and IgG, tissue transglutaminase IgA and IgG antibodies), documented vitamin or mineral deficiencies, albumin level, presence of ascites, history of uppergastrointestinal surgery, concomitant gastrointestinal orcolonic diseases, endoscopic appearance of the upper gastro intestinal tract, including evaluation for any structural abnormalities and any other medical conditions that might predispose the patient to SBBOS, such as portal hypertension orchronic renal failure.
Bacteriological analysis
The aspirated jejunal fluid which was transported in Robertson Cooked Meat broth (already diluted 1:10) was serially diluted further (1:100, 1:1,000) in phosphate buffer containing 1% peptone. Homogenized biopsy sample was also serially diluted (1:10, 1:100, 1:1,000), 20 μL of a specific dilution each of the fluid/homogenized mixture was inoculated onto 5 separate culture plates. The total bacterial count was assessed using Miles and Misra method (Miles AA and Misra SS, 1983) . The dilution which yielded countable colonies was used for computing the bacterial counts. The average number of colony counts per plate (i.e., per 20 μL) was calculated for every dilution. The culture media used for aerobic culture were chocolate agar, 5% sheep blood agar and MacConkey's medium. Qualitative anaerobic cultures were done directly from the RCM tube (without dilution) onto 5% sheep blood agar. The plates were incubated anaerobically in an anaerobic jar at 37ºC for 48 h. The total colony forming units (CFU) in jejunal fluid per mL and jejunal biopsy per gram were calculated by the following formulae for jejunal fluid and biopsy, respectively (Chandra et al., 2010) . (2) number of surface and crypt intraepithelial lymphocytes, (3)number of crypt apoptoses, (4) basal plasmacytosis, (5) neutrophilic cryptitis or villitis, (6) peptic duodenitis, (7) accompanying erosions or ulcers, (8) increased mucosal eosinophils, and (9)abnormal absence of goblet cells and/or Paneth cells. Villous length to crypt depth ratio was considered abnormal if it was less than 3:1 in well-oriented biopsy fragments. Intraepithelially mphocytosis was evaluated by counting the number of lymphocytes within the villous epithelium in the area of highestlymphocyte density after scanning the biopsy fragments at low power. Cases were categorized as normal if ≤ 20 lymphocytes per100 epithelial cells) or increased (21-40, 41-60, 61-80, and >80lymphocytes per 100 epithelial cells). Crypt intraepitheliallymphocytosis was evaluated in a similar fashion. For cryptapoptosis, any number greater than 5 apoptotic bodies per 10crypts was considered abnormal. Basal plasmacytosis was characterized by lymphoplasmacytic inflammation located between the muscularis mucosae and the base of the crypts with or without a qualitative increase in mononuclear cells in the intercryptal spaces and villi. We defined peptic change histologically as gastric foveolar metaplasia of the small-bowel epithelium and increased intramucosal Brunner glands in post bulb arbiopsies. Because there are no welldefined reference range foreosinophil counts in small-bowel lamina propria, the determination of increased mucosal eosinophils was subjective; we also considered anything more than rare intraepithelial eosinophils to be abnormal.
Statistical Analysis
Fisher exact test and t test were used to compare the SBBOS and control groups for categoric and noncategoric data, respectively. Two-tailed P values, .05 were considered significant.
Results
Clinical Features
The demographic data are summarized in Table 1 .Patients with SBBOS were on average older than controls (mean± SD,58.4 ± 11.7yearsversus50 ± 10.4years;P=< 0.05). The SBBOS and control groups had similar presenting symptoms, with diarrhea (54%; 15 of 28), weight loss (21%; 6 of 28),abdominal pain (25%; 7 of28), and abdominal bloating (29%; 8 of 28) being the most common symptoms in patients with SBBOS, and with diarrhea (62%; 13 of 21),abdominal pain (29%; 6 of 21), nausea (24%; 5 of21), and weight loss (19%; 4 of 21)reported most commonly in controls. A slight female predominance was present in both groups (SBBOS, 54%, 15 of 28; and control, 57%, 12 of 21, respectively; P = > 0.05).As expected, conditions that are known to predispose to bacterial overgrowth were more prevalent in the SBBOS group ( Table 2) : 68% of patients with SBBOS (19 of 28) had predisposing conditions as compared with only 38% (9 of 21) in the control group (P=< 0.05). The most common condition in both groups was the use of acid lowering medications. The presence of a blind loop was significantly more frequent in the SBBOS group than in controls (11% (3 of 28) vs5% (1 of 21); P = > 0.05). One patients (4%) with SBBOS had scleroderma, and another one (4%) had chronic pancreatitis; none of the patients in the control group had these conditions. 
Sensitivity testing
In vitro sensitivity to commonly used orally absorbed antibiotics showed (table4) that bacteria isolated from small bowel were more often sensitive to ciprofloxacin and amikacin than to other groups of antibiotics. 
Histology
The histologic findings are summarized in Table 3 .Patients with SBBOS were more likely to have architecturally abnormal duodenal biopsies, with a v:c ratio of less than 3:1in 7 (25%) of cases with SBBOS but in only 1 controls (5%; P<0.05; Figures 1 and 2, A) . In contrast, there were no significant differences between the 2 groups in any of the Otherhisto pathologic features, including villous and cryptintraepithelial lymphocytosis, crypt apoptoses, basal plasmacytosis, neutrophiliccryptitis/ villitis, erosion/ulcers, increased mucosal eosinophils, presence of goblet and Paneth cells, or peptic duodenitis (Figures 2, B, and  3) .Overall, 15 of the duodenal biopsies from patients with SBBOS (54%) were judged to be within reference range, whereas the other 46% (13 of 28) demonstrated one or morehistologic abnormalities. In the control group, there were slightly higher numbers of biopsies considered normal(62%; 13 of 21), but that difference was not statistically significant (P> 0.05). ]Aetiology of SBBOS is usually complex, associated with disorders of protective antibacterial mechanisms (e.g. achlorhydria, pancreatic exocrine insufficiency, immune deficiency syndromes), anatomical abnormalities (e.g. small intestinal obstruction, diverticula, fistulae, surgical blind loop, previous ileocaecal resections) and/or motility disorders (e.g. scleroderma, autonomic neuropathyin diabetes mellitus, post-radiation enteropathy, small intestinal pseudoobstruction). In some patients more than one factor may be involved (Paul et al., 2010) . Bacterial overgrowth can cause a variety of symptoms, many of which are also found in other conditions, making the diagnosis challenging at times (Sieczkowska et al., 2015) . Many of the symptoms are due to mal absorption of nutrients due to the effects of bacteria which either metabolize nutrients or cause inflammation of the small bowel impairing absorption. The symptoms of bacterial overgrowth include nausea, flatus, constipation, bloating, abdominal distension, abdominal pain or discomfort, diarrhea, fatigue, and weakness (Jan et al., 2010) . In this study we try to delineate the histopathologic features of SBBOS detectable in a routine pathology practice. All 49 patients in our study had prolonged gastrointestinal symptoms, and all were diagnosed as having-or not having-SBBOS by duodenal or jejunal aspirate cultures (considered to be the diagnostic gold standard for bacterial overgrowth). As expected, there were some clinical differences between SBBOS cases and controls. Patients with SBBOS were on average older than patients without SBBOS(mean± SD,58.4 ± 11.7years versus 50 ± 10.4years; P=< 0.05), underscoring prior studies that have shown a higher prevalence of SBBOS in elderly patients who are more likely to suffer from altered gut motility, poor nutrition, and/or medical conditions that predispose them to bacterial overgrowth (Donald et al., 1999) . In our study, patients with SBBOS were also more likely to have one or more risk factors for bacterial overgrowth (68% versus 38%; P=< 0.05).Numerous conditions have been associated with SBBOS including blind loop, surgical adhesions, scleroderma, diabetes, chronic pancreatitis, and intestinal dysmotility (Braun et al., 2015, Mooney et al., 2015 , Lauritano et al., 2007 ). We included use of acid-lowering medications as a possible risk factor, although it is likely not a strong one (Fujimori et al., 2015) . These medications were common in both SBBOS (54%; 15 of 28)and controls (33%; 7 of 21), but even if this factor is disregarded, the results remain statistically significant (P< 0.05). Aside from age and background risk factors, the 2groups were similar. In particular, there was a marked overlap in presenting symptoms, with diarrhea and abdominal pain being the most common indications for small bowel biopsy in both SBBOS cases and control cases. Several studies suggest that SIBO is much more common in the general population than previously thought and that it is frequently under diagnosed. For example, Teo et al (Teo et al., 2004) prospectively studied 87 consecutive patients with chronic diarrhea, and SBBOS was by far the most frequent etiology, accounting for symptoms in 48%of cases (n = 42), whereas irritable bowel syndrome accounted for only 13% (n =11). There is also increasing evidence that SBBOS may be the underlying etiology in some cases of irritable bowel syndrome, which is currently the most common diagnosis rendered in gastroenterology practice (Posseurd et al., 2007) . Pimental et al2000 used lactulose hydrogen breath testing to evaluate for SBBOS in 202 patients with a clinical diagnosis of irritable bowel syndrome and obtained positive results in 78% (n 5 158). Although breath tests suffer from lack of specificity, in the Pimentelet al 2000 study, eradication of SBBOS after antibiotic therapy was significantly associated with improvement in symptoms of diarrhea and abdominal pain, to the extent that48% of subjects who achieved eradication (n = 97) no longer met clinical criteria for irritable bowel syndrome.
Figure 1: Partial villous atrophy with villous to crypt ratio of1:1,without intraepithelial lymphocytes is seen in a case with SBBOS (hematoxylin-eosin, X100).
Figure 2: A, Partial villous blunting with villous to crypt ratio of1:1.B,Intraepithelial lymphocytosis (arrows) in a case with SBBOS(hematoxylin-eosin,X200[A] andX400[B]).
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Figure 3: Histologic features occasionally seen in SBBOS, including (A) increased crypt apoptoticbodies(arrows);(B)basalplasmacytosischaracterizedbylymphoplasmacyticinflammationlocatedbetweenthemusculari smucosaeandthebaseofthecrypts(arrows);and(C)neutrophiliccryptitis(arrows)(hematoxylin-eosin, original magnificationsX400).
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The present study has demonstrated that the culture of jejunal biopsy yields results similar to fluid with respect to presence of growth, nature of organisms.
It was found that the predominant Gram positive organism was streptococcus species and the predominant Gram negative organism was Escherichia coli. This is accordance with the earlier report from the west (Bouhnik et al., 1999) . We found frequent resistance to Ampicillin-clavulanic acid and Trimethoprim-sulfamethoxazole that are often used in the treatment of SIBO. This is in accordance with Ghoshal et al (2003) but it is in contrast to an western report showing infrequent resistance to most antibiotics (Bouhnik et al., 1999) These discrepancies might be explained by differing practice of antibiotic use in different countries. Frequent resistance to commonly used antibiotics in Egypt might owe to frequent unnecessary use of these antibiotics. Most of bacteria isolated were sensitive to both ciprofloxacin and Amikacin. However, ciprofloxacin may be preferred over Amikacin, since ciprofloxacin can be given orally and therefore, may have in frequent side effects. Patients with SIBO often need long-term and repeated courses of antibiotics and therefore, those with lesser toxicity and lower systemic absorption would be preferred Histologically, we found that modestarchitectural distortion was the most common abnormality in SBBOS. Villous blunting was present in 25% of SBBOS biopsies (7 of 28) but only 5% of controls (1 of 21; P=< 0.01). Lymphocytosiswithin villous epithelium was also slightly more frequent in SBBOS (21%; 6 of 28) than in controls Overall, 54% of duodenal biopsies from patients with SBBOS (15 of 28) and64% of biopsies from symptomatic controls (13 of 21) in our study population were within histologic reference range. The high rate of histologically ''normal'' biopsies does not negate the pathogenic role of bacterial overgrowth in symptomatic patients. It has been hypothesized that excess colonic flora within the small intestine can impede fat digestion by deconjugating bile acids and hindering the formation ofmicelles, that these bacteria can induce vitamin B12deficiency, and that they can result in osmotic or secretorydiarrhea through the production of organic acids, free bileacids, fatty acids, and other organic acids (Camp et al., 2009 ). All of these proposed mechanisms can coexist with microscopically healthy small bowel mucosa. Overall, the published findings related to the light microscopic findings in SBBOS are based on studies of small numbers of patients, use varying diagnostic tests to define SBBOS, and have included control groups that range from truly healthy patients to patients with diarrhea-predominant irritable bowel syndrome. The results of these studies have been conflicting. Ament et al(1972) found mild to moderate villous blunting and increased cellularity in the lamina propria in 3 of 3patients (100%) studied but emphasized the patchy nature of these abnormalities in the numerous biopsies taken from these patients. In contrast, Riordan et al(2001) reported no differences in villous height, crypt depth, or v:cratiobetween 26 patients with SBBOS and 26 controls.
In summary, our results show that only approximately half of small intestinal biopsies from symptomatic patients with a gold standard diagnosis of SBBOS show any histologic abnormality on routine hematoxylin-eosin examination.
When abnormalities are present (most commonly villous blunting or increased intraepithelial lymphocytes) they are typically mild and relatively nonspecific. Therefore, when trying to determine the etiology for a patient's upper gastrointestinal symptoms, both pathologists and gastroenterologists should be aware of the limitations of histology in diagnosing, suggesting, or ruling out SBBOS. Small-bowelbiopsies remain extremely important in the evaluation for other gastrointestinal diseases (eg, celiac disease and pepticduodenitis), but if SBBOS is a diagnostic consideration then specific clinical or microbiologic testing for bacterial over growth should also be performed.
